Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Inventory (2016 - 2025)

Historic Inventory for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to $128.8 million.

  • Orthopediatrics' Inventory rose 651.02% to $128.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $128.8 million, marking a year-over-year increase of 651.02%. This contributed to the annual value of $117.0 million for FY2024, which is 1053.75% up from last year.
  • As of Q3 2025, Orthopediatrics' Inventory stood at $128.8 million, which was up 651.02% from $125.3 million recorded in Q2 2025.
  • In the past 5 years, Orthopediatrics' Inventory registered a high of $128.8 million during Q3 2025, and its lowest value of $55.3 million during Q1 2021.
  • In the last 5 years, Orthopediatrics' Inventory had a median value of $91.0 million in 2023 and averaged $91.1 million.
  • In the last 5 years, Orthopediatrics' Inventory skyrocketed by 3582.31% in 2022 and then skyrocketed by 626.77% in 2025.
  • Orthopediatrics' Inventory (Quarter) stood at $57.6 million in 2021, then skyrocketed by 35.82% to $78.2 million in 2022, then skyrocketed by 35.37% to $105.9 million in 2023, then grew by 10.54% to $117.0 million in 2024, then rose by 10.09% to $128.8 million in 2025.
  • Its Inventory was $128.8 million in Q3 2025, compared to $125.3 million in Q2 2025 and $119.8 million in Q1 2025.